Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Tobacco Use Disorder

• Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO)
• Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
• Nicotine and Pavlovian Bias
• Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
• Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction
• Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
• Cytisine for Smoking Cessation
• Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
• Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking
• Orexin's Role in The Neurobiology of Substance Use Disorder
• Beta-Adrenergic Modulation of Drug Cue Reactivity
• Effects of Semaglutide on Nicotine Intake
• Smoking Cessation and Menstrual Cycle Phase: A Randomized Controlled Trial
• A Mechanistic Test of Treatment Strategies to Foster Practice Quitting
• The Effects of Sedatives on Tobacco Use Disorder Version 2
• Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
• 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
• Oral Cannabidiol for Tobacco Cessation
• Varenicline for Nicotine Vaping Cessation in Adolescents
• Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans
• Methadone-Maintained Smokers Switching to E-Cigarettes
• IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
• Nicotine Differences in Smokers
• Mind to Quit Multisite Trial
• A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers
• Reduced Nicotine Cigarette Purchasing Decisions
• Research and Innovation to Stop E-cigarette/Vaping in Young Adults
• UW Withdraw From Tobacco Study
• Quit Smoking Study for People Who Use E-Cigarettes
• Study of EMB-001 as a Potential Smoking Cessation Treatment
• Acute Effects of Vaping Nicotine on Cognition in Young Adults
• Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
• E-cigarette Nicotine Study
• Do Flavors Increase the Addiction Potential of Nicotine?
• N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use
• Learn to Quit-HIV Pilot Study
• Varenicline For Vaping Cessation In Non Smoker Vaper Adolescents
• Varenicline for Co-occurring Cannabis and Tobacco Use
• Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy
• Development of a mHealth Intervention for Ambivalent Smokers
• Nicotine's Potential Abuse With Menthol
• Effects of Menthol in E-cigarettes on Smoking Behaviors
• A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
• Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
• Mechanisms of Lorcaserin for Smoking Cessation
• The Interaction of Flavor With Nicotine Form in Adult Smokers
• Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
• Cannabis and Tobacco Co-use Study
• Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
• Cessation Screening Project
• Optimizing Tobacco Use Treatment for PLWHA
• Enhancing Self Regulation Among Smokers
• Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy
• Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
• Deep rTMS and Varenicline for Smoking Cessation
• Brain Imaging in Tobacco Smokers During a Quit Attempt
• Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
• Targeting Orexin to Treat Nicotine Dependence
• VIP Smoking Cessation Intervention for Adults With Serious Mental Illness
• Persistence Targeted Smoking Cessation in Schizophrenia
• Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco
• Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
• Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence
• The Effects of Sedatives on Tobacco Use Disorder
• Comparing NicoBloc to Nicotine Lozenges
• An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
• Daily Liraglutide for Nicotine Dependence
• Effects of E-Cigarette Flavors on Adults TCORS 2.0
• Effects of E-cigarette Flavors on Youth TCORS 2.0
• The PROMPT Pilot Study
• Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
• Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
• Varenicline OTC Trial on Efficacy and Safety
• To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
• A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
• The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
• AXS-05 Phase II Trial on Smoking Behavior
• Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction
• A Trial of Directly Observed and Long-term Varenicline
• End Nicotine Dependence Clinic
• Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
• Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers
• Glucocorticoid Antagonist Treatment for Tobacco Use Disorder
• Effects of Flavors on Nicotine Reinforcement in Smokers
• UW Quitting Using Intensive Treatment Study (QUITS)
• Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
• A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.
• Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
• Stage Ib Trial of mSMART With Varenicline
• Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness
• Personalized Dosing of Nicotine Replacement (NRT to Effect)
• Treating Smokeless Tobacco Use in Rural Veterans
• Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
• Combination Nicotine Patch / Lorcaserin for Smoking Cessation
• Nicotine Replacement Therapy in Nicotine-dependent Arrestees
• Optimizing Tobacco Dependence Treatment in the Emergency Department
• Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
• Extended Varenicline Treatment for Smoking Among Cancer Patients
• Study on Sit to Quit Phone Intervention
• RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers
• N-acetylcysteine for Tobacco Use Disorder
• Translational Neuropsychopharmacology Research of Nicotine Addiction
• Combining Varenicline and Naltrexone for Smoking Cessation
• Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
• Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
• Babies Living Safe and Smokefree
• Effects of Intranasal Oxytocin on Cigarette Smoking
• Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
• Effect of Ramelteon on Smoking Abstinence
• TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence
• Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette
• Adaptive Pharmacotherapy for Smoking Cessation
• Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment
• The END Perioperative Smoking Pilot Study
• Treatment for Nicotine Addiction in Women
• Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
• Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
• Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)
• The Study of AZD8529 for Smoking Cessation in Female Smokers
• Lorcaserin for Preventing Weight Gain Among Smokers
• Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
• Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
• Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers
• Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
• Medicinal Nicotine for Preventing Cue Induced Craving
• Varenicline and Combined NRT for Smoking Cessation
• Novel Medication as a Potential Smoking Cessation Aid
• Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers
• Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
• Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women
• Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1
• Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
• A Quit Smoking Study Using Smartphones
• New Approaches to Smoking Cessation in Heavy Drinkers
• Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers
• The MATCH (Medication Aids for Tobacco Cessation and Health) Study
• Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
• Electronic Cigarettes in Daily Dependent Smokers
• The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
• Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
• A Dietary Supplement for Early Cigarette Withdrawal
• Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation
• Very Low-Nicotine Cigarettes in Smokers With SUD
• Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy
• Progesterone for Smoking Relapse Prevention Following Delivery
• Smoking Cessation for People Living With HIV/AIDS
• Progesterone and Brain Imaging Study
• Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
• Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
• Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
• Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status
• Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
• e-Cigarettes Versus NRT Gum for Smoking Cessation
• Brain Networks and Addiction Susceptibility
• Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
• A Study to Help People Quit Smoking.
• Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction
• Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
• Effect of Galantamine on Short-term Abstinence
• D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS)
• Acute and Chronic Nicotine Modulation of Reinforcement Learning
• Baclofen Effects in Cigarette Smokers
• Smoking, Sex Hormones, and Pregnancy
• Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
• Progesterone & Postpartum Relapse to Smoking
• Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers
• Helping Those With Mental Illness Quit Smoking
• Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
• Extended Varenicline Treatment for Smoking Among Cancer Patients
• Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
• Progesterone and Atomoxetine for Cocaine Cessation
• Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence
• Varenicline for Nicotine Dependence Among Those With HIV/AIDS
• Nicotinic Receptor Levels After Stopping Smoking
• Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm
• Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
• Effect of Galantamine on Short-term Abstinence
• Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
• Nicotine Replacement for Smoking Cessation During Pregnancy
• Persistence-Targeted Smoking Cessation
• Prazosin for Smoking Cessation
• The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
• Varenicline on Reward Responses and Cognition in Adolescent Smokers
• Bupropion Alone or Combined With Nicotine Gum
• Bupropion SR Plus Counseling for Smoking Cessation
• Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
• Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs
• IV Nicotine Induced Changes in Hormone Function, Mood States and Behavior
• Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels
• The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking
• Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia
• Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
• A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers
• Effect of Galantamine on Smoking Abstinence
• Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
• Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
• Effects of Varenicline on Smoking Reminders
• Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
• Varenicline for Adolescent Smoking Cessation
• Nicotine Reinforcement and Aversion in Young Adult Light Smokers
• A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
• An Exploratory Study Comparing Two Nicotine Inhalers
• Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
• Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
• A Study on the Effects of Two Nicotine Replacement Products on Tooth Staining
• Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
• Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
• Pioglitazone for Heroin and for Nicotine Dependence
• Bupropion for Smoking Cessation During Pregnancy
• Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients
• Evaluation of Learning-Theory-Based Smoking Cessation Strategies
• Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum
• Varenicline Treatment for Active Alcoholic Smokers
• Selegiline Patch for Treatment of Nicotine Dependence
• Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
• Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products
• Pharmacogenetics of Nicotine Addiction Treatment
• Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
• Concurrent Bupropion / Varenicline for Smoking Cessation
• Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
• Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
• Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab
• Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg
• Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
• Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
• Baclofen for Smoking Cessation in a Non-Psychiatric Population
• Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
• Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
• Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers
• Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
• Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence
• Tailoring Varenicline to Individual Needs (TVIN Study)
• Medications Development for the Treatment of Cannabis Related Disorders
• Pilot Study of Tolcapone in Smokers
• Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
• Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
• New Treatment for Alcohol and Nicotine Dependence
• Varenicline and Alcohol in Inpatient Addictions Program (IAP)
• Maintaining Nonsmoking
• Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum
• Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum
• Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum
• Enhancing a High School Based Smoking Cessation Program
• Smoking Termination Opportunity for inPatients
• Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray
• Identifying Treatments to Motivate Smokers to Quit
• Evaluation of Treatments to Improve Smoking Cessation Medication Adherence
• Identifying Optimal Smoking Cessation Intervention Components (Cessation)
• Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum
• Efficacy of Varenicline for Smokeless Tobacco Use in India
• Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder
• Varenicline For Smokers In Recovery From Alcohol Dependence
• Tobacco Dependence Treatment for Asian Americans
• Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.
• Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product
• Investigation of Cycloserine as a Smoking Cessation Treatment
• Coping Skills Treatment for Smoking Cessation
• Innovative Interventions for Smoking Cessation
• Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
• An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
• Effects of Nicotine on Brain Opioid Receptors
• Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers
• Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
• Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
• Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
• STOP Study: Effectiveness of Zyban in a Clinical Population
• Neural Substrates in Nicotine Withdrawal
• Nicotine Vaccination and Nicotinic Receptor Occupancy
• Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users
• Sensitivity to Intravenous Nicotine: Genetic Moderators
• N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
• Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes
• Acceptability of Less Harmful Alternatives to Cigarettes
• Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
• Effects of Chantix on Relapse Prevention for Smoking Cessation
• Measuring Smoking Behaviors While Using Varenicline
• Treatment of Smoking Among Individuals With PTSD
• Bupropion for ADHD in Adolescents With Substance Use Disorder
• Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
• Efficacy and Safety of Varenicline Among HIV-infected Patients
• Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence
• Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy
• Effect of Varenicline on Reactivity to Smoking and Drinking Cues
• Varenicline for Smoking Cessation in Heavy Drinking Smokers
• Extinction Based Treatment for Nicotine Dependence
• Varenicline for the Treatment of Smokeless Tobacco
• Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
• Use of Varenicline for 4-weeks Prior to Quitting
• Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
• Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
• Varenicline and Motivational Advice for Smokers With Substance Use Disorders
• Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study
• N-Acetylcysteine and Smoking Reduction
• Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence
• Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment
• Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement
• Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
• Effects of Varenicline on Cigarette Self Administration
• Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
• S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
• Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
• Human Laboratory Study Of Varenicline in Smokers
• Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers
• Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
• Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
• Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
• GABA (Gamma Amino Butyric Acid) Medication for Tobacco
• Nicotine Patch Pretreatment for Smoking Cessation in PTSD
• Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail
• Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia
• Effects of Varenicline on Brain Activity During Nicotine Abstinence
• Assessment of a Teachable Moment for Smoking Cessation
• Efficacy of Varenicline in Ambivalent Smokers
• Chantix & Bupropion for Smoking Cessation
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
• Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
• Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt
• Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
• A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
• Testing Methylphenidate for Smoking Abstinence
• Varenicline Effects In Schizophrenic Smokers
• A Randomized Trial of Internet Access to Nicotine Patches
• Bupropion in Helping Adults Stop Smoking
• Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban
• Pharmacogenetics, Emotional Reactivity and Smoking
• Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
• The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
• Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation
• Reduction of Smoking in Cardiac Disease Patients
• Health Effects of SLT, Cigarette Smoking, and New Tobacco Products
• Extended Cessation Treatment for Teen Smokers
• Selegiline for Smoking Cessation - 1
• Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
• Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
• Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
• St. John's Wort for Tobacco Cessation
• A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.
• Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence
• Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
• Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
• Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
• Bupropion Treatment for Youth Smoking Cessation
• Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
• Combined Pharmaco/Behavior Therapy in Adolescent Smokers
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
• Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
• Group Therapy for Nicotine Dependence: Mindfulness and Smoking
• Smoking Cessation Intervention: Effectiveness in Primary Care
• Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation
• Effect of Progesterone on Smoking Behavior in Male and Female Smokers
• Effects of Naltrexone on Nicotine Reinforcement
• The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers
• Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents
• Baclofen Effects on Smoking Urge and Withdrawal
• Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
• A Feasibility Study of Smoking Cessation Program in Radiation Oncology
• Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
• Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
• Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
• Nicotine Lozenge to Reduce Smokeless Tobacco Use
• Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use
• Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
• Naltrexone Augmentation of Nicotine Patch Therapy - 1
• Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1
• A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
• Treatment of Nicotine Dependence and Acute Depression
• A Comparison of Bupropion SR and Placebo for Smoking Cessation
• Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
• Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
• Bupropion as an Adjunct to the Nicotine Patch Plus CBT
• Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
• Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
• The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
• Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2
• Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
• Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
• Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
• Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
• Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women
• Nicotine Replacement Treatment for Pregnant Smokers - 1
• Non-Nicotine Agents for Smoking Cessation
• Brain Reaction to Treatment of Nicotine Dependence
• Targeted Interventions for Weight-Concerned Smokers
• Framing Messages for Smoking Cessation With Bupropion - 6
• Maintaining Abstinence in Chronic Cigarette Smokers - 1
• Comparing Smoking Treatment Programs for Lighter Smokers - 1
• Maintaining Nonsmoking: Older Smokers - 1
• Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
• Maintenance Treatment for Abstinent Smokers
• Tobacco Cessation in Postmenopausal Women (Part II) - 2
• Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
• Bupropion and Weight Control for Smoking Cessation - 1
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
• Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
• Effects of Labetalol on Nicotine Administration in Humans - 14
• Role of Metabolites in Nicotine Dependence (4) - 13
• Progesterone Treatment in Female Smokers - 12
• Role of Metabolites in Nicotine Dependence (3) - 6
• Role of Metabolites in Nicotine Dependence (2) - 5
• Role of Metabolites in Nicotine Dependence (1) - 1